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Identity 
HGNC (Hugo): TAL2 
Location: 9q31 
Local order: from centromere to telomere: CSDUFD1, 
MGC45564, FCMD, TAL2, C9ort87, ZNF462 
DNA/RNA 
Description 
Exons 1a, 2, 3, and 1b located 5-8 kb upstream of exon 
4; coding region in exon 4 (326 bp). 
Transcription 
Various mRNA isoforms were found in SUP-T3 and in 
the mouse, which also encompass upstream exons; 
gene products, however, always corresponded to the 
TAL2 protein encoded by exon 4. 
Protein 
Description 
108 amino acids; basic Helix Loop Helix motif for 
protein dimerization and DNA-binding. 
Expression 
In adult testes; in developing midbrain, dorsal 
diencephalon, rostroventral diencaphalic/ telencephalic 
boundary, and anterior pons; pivotal role in the 
development of the mature central nervous system; not 
expressed during normal hematopoietic development. 
Function 
Transcription factor; TAL2 dimerizes with members of 
the class A subgroup of bHLH proteins (ie E47, E12, 
E2-2, HEB), as well as LIM-only proteins LMO1 and 
LMO2; heterodimers are formed intracellularly through  
stable interaction between bHLH domains of TAL2 and 
E47; TAL2/E47 heterodimers bind DNA in a sequence-
specific manner that is dependent on the E-box 
element; TAL2/E12 heterodimers also have DNA-
binding activity; TAL2 does not bind DNA in absence 
of E2A proteins; a significant fraction (60%) of TAL2 
polypeptides from SUP-T3 exist in phosphorylated 
form, the rest is unphosphorylated; serine residue 100 
of TAL2 is the potential site of phosphorylation by 
MAP kinases. 
Homology 
TAL1 at 1p31, LYL1 at 19p13; TAL2, TAL1, and 
LYL1 share more than 85% amino acid identity in the 
bHLH domain and are thus more related to one other 




T cell acute lymphoblastic leukemia found in < 1% of 
ALL, in 1-2% of T-ALL, rare but recurrent. 
Hybrid/Mutated gene 
Translocation of part of TCRB locus to a breakpoint 33 
kb downstream of TAL2 mediated by the V(D)J 
recombinase via a fortuitous recombination signal 
sequence (YRSS) on chromosome 9; the translocation 
results in a signal joint fusion of TAL2 YRSS with the 
Db1 23-RSS; this gene product was detected in 6 of 10 
thymus samples of healthy children with an estimated 
frequency of 1 in 10 million thymic cells; only upon  
secondary rearrangement of the TAL2/Db signal joint 
to the Jb2.6 segment, and deletion of the intervening 
sequence, the typical TAL2/Jb2.6 T-ALL junctions 
could be observed which presumably lead to 
overexpression of TAL2 and development of leukemia. 
 










TAL2 placed under control of TCRB enhancer leading 
to overexpression of TAL2 in T-cells and development 
of leukemia. 
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